Fundz

Gemelli Biotech Corp. reported raising $1.85 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEJun 28, 2019$1.9M of $3M raised

Amount Raised

$1.85 Million

$1.85 Million sold, per SEC Form D (first sale Jun 28, 2019)

Round Type

Seed

RaleighBiotechnology

Quick answer

Gemelli Biotech raised $1.85 Million in a Seed round, dated June 28, 2019. Gemelli Biotech is based in Raleigh, North Carolina, United States.

How much did Gemelli Biotech raise?
Gemelli Biotech raised $1.85 Million in a Seed round on June 28, 2019.
What does Gemelli Biotech do?
Gemelli Biotech leverages leading biological discoveries related to the microbiome to provide non-invasive precision diagnostics which enable clinicians to definitively detect scientifically validated biomarkers and..
Where is Gemelli Biotech based and how big is it?
Gemelli Biotech is based in Raleigh, North Carolina, United States.
Who are the decision-makers at Gemelli Biotech?
Fundz holds 2 contacts at Gemelli Biotech, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Gemelli Biotech that raised within 45 days of this round, from Fundz verified event records.

  • Artax Biopharma raised $750K (Seed) on August 12, 2019.
  • Xione Therapeutics, Inc. raised $90K (Pre-Seed) on August 12, 2019.
  • MimiVax raised an undisclosed amount on August 12, 2019.
  • Intus Bio raised $885K on August 12, 2019.
  • MED-X raised $467K on August 9, 2019.
  • Alaunos Therapeutics raised $105M on August 9, 2019.

Who to call at Gemelli Biotech, and when

A new round usually means Gemelli Biotech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gemelli Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gemelli Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gemelli Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gemelli Biotech

Location

2009 Fairview Rd. #6099

Raleigh, North Carolina, United States

About

Gemelli Biotech leverages leading biological discoveries related to the microbiome to provide non-invasive precision diagnostics which enable clinicians to definitively detect scientifically validated biomarkers and optimally treat GI diseases including SIBO, IMO, excess hydrogen sulfide and post-infectious IBS.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gemelli Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMatthew M., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Gemelli Biotech's next move

See what Strategic adds

Gemelli Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.